 | Up a level |
Poustchi, H. and Darvishian, M. and Mohammadi, Z. and Shayanrad, A. and Delavari, A. and Bahadorimonfared, A. and Eslami, S. and Javanmard, S.H. and Shakiba, E. and Somi, M.H. and Emami, A. and Saki, N. and Hormati, A. and Ansari-Moghaddam, A. and Saeedi, M. and Ghasemi-Kebria, F. and Mohebbi, I. and Mansour-Ghanaei, F. and Karami, M. and Sharifi, H. and Pourfarzi, F. and Veisi, N. and Ghadimi, R. and Eghtesad, S. and Niavarani, A. and Ali Asgari, A. and Sadeghi, A. and Sorouri, M. and Anushiravani, A. and Amani, M. and Kaveh, S. and Feizesani, A. and Tabarsi, P. and Keyvani, H. and Markarian, M. and Shafighian, F. and Sima, A. and Sadjadi, A. and Radmard, A.R. and Mokdad, A.H. and Sharafkhah, M. and Malekzadeh, R. (2021) SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. The Lancet Infectious Diseases.
Poustchi, H. and Darvishian, M. and Mohammadi, Z. and Shayanrad, A. and Delavari, A. and Bahadorimonfared, A. and Eslami, S. and Javanmard, S.H. and Shakiba, E. and Somi, M.H. and Emami, A. and Saki, N. and Hormati, A. and Ansari-Moghaddam, A. and Saeedi, M. and Ghasemi-Kebria, F. and Mohebbi, I. and Mansour-Ghanaei, F. and Karami, M. and Sharifi, H. and Pourfarzi, F. and Veisi, N. and Ghadimi, R. and Eghtesad, S. and Niavarani, A. and Ali Asgari, A. and Sadeghi, A. and Sorouri, M. and Anushiravani, A. and Amani, M. and Kaveh, S. and Feizesani, A. and Tabarsi, P. and Keyvani, H. and Markarian, M. and Shafighian, F. and Sima, A. and Sadjadi, A. and Radmard, A.R. and Mokdad, A.H. and Sharafkhah, M. and Malekzadeh, R. (2021) SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. The Lancet Infectious Diseases, 21 (4). pp. 473-481.
